Literature DB >> 21586285

Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation.

Chao Chen1, Chao-Qun Wu, Zong-Qi Zhang, Ding-Kang Yao, Liang Zhu.   

Abstract

Activation and migration of resident stellate cells (HSCs) within the hepatic space of Disse play an important role in hepatic fibrosis, which accounts for the increased numbers of activated HSCs in areas of inflammation during hepatic fibrosis. Currently, microRNAs have been found to play essential roles in HSC differentiation, proliferation, apoptosis, fat accumulation and collagen production. However, little is known about microRNA mediated HSC activation and migration. In this study, the miRNA expression profiles of quiescent HSCs, partially activated HSCs and fully activated HSCs were compared in pairs. Gene ontology (GO) and GO-Map network analysis indicated that the activation of HSCs was regulated by microRNAs. Among them miR-335 was confirmed to be significantly reduced during HSC activation by qRT-PCR, and restoring expression of miR-335 inhibited HSC migration and reduced α-SMA and collagen type I. Previous study revealed that tenascin-C (TNC), an extracellular matrix glycoprotein involved in cell migration, might be a target of miR-335. Therefore, we further studied the TNC expression in miR-335 over-expressed HSCs. Our data showed that exogenous TNC could enhance HSC migration in vitro and miR-335 restoration resulted in a significant inhibition of TNC expression. These results demonstrated that miR-335 restoration inhibited HSC migration, at least in part, via downregulating the TNC expression.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586285     DOI: 10.1016/j.yexcr.2011.05.001

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  42 in total

1.  MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1.

Authors:  Feng Qi; Jiang-Feng Hu; Bao-Hai Liu; Chao-Qun Wu; Hong-Yu Yu; Ding-Kang Yao; Liang Zhu
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

2.  MicroRNAs in hepatic pathophysiology in diabetes.

Authors:  Kirandeep Kaur; Himanshi Bhatia; Malabika Datta
Journal:  World J Diabetes       Date:  2011-10-15

Review 3.  Delivery and targeting of miRNAs for treating liver fibrosis.

Authors:  Virender Kumar; Ram I Mahato
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

Review 4.  Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?

Authors:  Ningling Kang; Vijay H Shah; Raul Urrutia
Journal:  Mol Cancer Res       Date:  2014-12-29       Impact factor: 5.852

Review 5.  The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis.

Authors:  Sanchari Roy; Fabian Benz; Tom Luedde; Christoph Roderburg
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

Review 6.  Reversibility and heritability of liver fibrosis: Implications for research and therapy.

Authors:  Hussein M Atta
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

7.  miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.

Authors:  Lei Shi; Dongyi Jiang; Guan Sun; Yi Wan; Shuguang Zhang; Yanjun Zeng; Tianhong Pan; Zhimin Wang
Journal:  J Neurooncol       Date:  2012-08-14       Impact factor: 4.130

8.  MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).

Authors:  Émilie A Graham; Jean-François Mallet; Majed Jambi; Hiroshi Nishioka; Kohei Homma; Chantal Matar
Journal:  Cancer Biol Ther       Date:  2017-09-08       Impact factor: 4.742

9.  Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma.

Authors:  Fang Wang; Ling Li; Klaus Piontek; Masazumi Sakaguchi; Florin M Selaru
Journal:  Hepatology       Date:  2018-01-29       Impact factor: 17.425

10.  Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation.

Authors:  Xu Sun; Yong He; Tao-Tao Ma; Cheng Huang; Lei Zhang; Jun Li
Journal:  Mol Cell Biochem       Date:  2013-11-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.